EFISCIENS is involved in numerous therapeutic scopes to revive treatments and protocols.
Since few years, the company has developed, made acquisitions and alliances in the following disciplines: Oncology, Transplant, Radiotherapy and Supportive Care.
Our Laboratory also has interests in Emergency Care, Endocrinology and Psychiatric Diseases.
EFISCIENS is committed to excellence and are engaged to improving and/or reintroducing products in each of these therapeutic areas.
EFISCIENS offer supportive care for patients expecting bone marrow transplant. Mostly used as alkylating agent in first-line therapy to guarantee transplant protocol.
Last clinical studies show that all lipid formulations of invasive fungal infections are effective in prophylaxis to patients with acute myelogenous leukaemia and myelodysplastic syndromes undergoing induction chemotherapy.
Used in prophylaxis of invasive fungal infections to patients under transplant protocol, EFISCIENS is one of the best alternative to supply supportive care products with two effective products in first-line therapy for transplants.
Our Laboratory is involved to reviving care for patients suffering of different types of cancer like small cell lung, non-hodgkin lymphoma disease and mycosis Fungoides or para-psoriasis.
Most of them are alkylating agent that produces a cytotoxic action that prevents the rapid proliferation of cancer cells or curative chemotherapy.
Our laboratory provides one original antiemetic drug which is including in chemotherapy protocol as supportive care.
Our Laboratory offer support to take care patients suffering tachycardia to eclampsia even vital prognostic engaged.
-Emergency treatment of junctional tachycardia, also used as an aid for diagnosing wide or narrow complex tachycardia.
-Emergency treatment of sympathetic tachycardia and some forms of cardiac arrhythmia.
-Some pre-eclampsia involving serious life-threatening breast.
We perform to preserve access to emergency care or on-going therapeutics, cure therapy for the benefit of each Life over the World.
Our Laboratory is supporting patients suffering Addison's disease which is a rare chronic condition brought about by the failure of the adrenal glands.
EFISCIENS is also looking to sustain patients suffering Graves-Basedow’s disease. This is an autoimmune disorder of the endocrine system. The stimulation attacks the thyroid gland, and it is the most common cause of hyperthyroidism.
EFISCIENS sustain patients suffering Chemotherapy and/or Radiotherapy side effects.
Collateral damages are mostly hard pains for gingival, parotid and/or salivary gland alteration, xerostomia, Sjogren’s syndrome, oesophageal soreness, dry mouth, burn or radiation dermatitis.
EFISCIENS provide a new range of products to relief patients exposed to such adverse effects and them guarantees a better quality life to pursue their therapies..
EFISCIENS should be delighted to have available a non-specific, non-reversible, antidepressant, psycho stimulant, MAO inhibitor that is effective in the treatment of various anxieties (panic attacks, phobia even post-traumatic stress) and/or depressive disorders.
Our laboratory offer availability of one anti psychotic which is a genuine opportunity to improve the range of pharmacological strategies available. The weekly dose makes dosage adjustment easier, and the oral administration is much more acceptable than any treatment by injection. In this context, there is no doubt that our anti psychotic should find a significant place among the specialist treatments prescribed for schizophrenic spectrum disorders.